Manufacturer:

Pfizer

Name:

OXALIPLATIN

Category:

J Code

HCPCS:

J9263

NDC(s):

00781-3315-70, 00781-3317-80, 00781-9315-70, 00781-9317-80, 00955-1725-10, 00955-1727-20, 00955-1731-10, 00955-1733-20, 16729-0332-03, 16729-0332-05, 25021-0233-10, 25021-0233-20, 43066-0014-01, 43066-0018-01, 45963-0611-53, 45963-0611-59, 47335-0046-40, 47335-0047-40, 47335-0176-40, 47335-0178-40, 50742-0405-10, 50742-0406-20, 51991-0218-98, 51991-0219-98, 55150-0331-01, 55150-0332-01, 60505-6132-06, 60505-6132-07, 60505-6132-08, 61703-0363-18, 61703-0363-22, 63323-0750-10, 63323-0750-20, 67457-0442-20, 67457-0469-10, 68001-0468-36, 68001-0468-37, 70860-0201-10, 70860-0201-20, 71288-0101-10, 71288-0101-20, 72266-0125-10, 72266-0126-10, 72266-0161-01, 72266-0162-01, 72603-0101-01, 72603-0301-01, 00703-3985-01, 00703-3986-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

OXALIPLATIN is a Cancer drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J9263 is aligned to the drug OXALIPLATIN.